Source:http://linkedlifedata.com/resource/pubmed/id/14978092
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2004-2-23
|
| pubmed:abstractText |
Statins, the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, are effective serum cholesterol-lowering agents in clinical practice, and they may also have anti-inflammatory properties. Asthma is characterized by chronic eosinophilic inflammation in the airways, which is thought to be regulated by the activity of T lymphocytes. We therefore examined the anti-inflammatory activity of simvastatin in a murine model of allergic asthma. In mice previously sensitized to OVA, simvastatin treatment, either orally or i.p., reduced the total inflammatory cell infiltrate and eosinophilia in bronchoalveolar lavage fluid in response to inhaled OVA challenge. Simvastatin therapy i.p. was also associated with a reduction in IL-4 and IL-5 levels in bronchoalveolar lavage fluid and, at higher doses, a histological reduction in inflammatory infiltrates in the lungs. OVA-induced IL-4, IL-5, IL-6, and IFN-gamma secretion was reduced in thoracic lymph node cultures from simvastatin-treated mice. Simvastatin treatment did not alter serum total IgE or OVA-specific IgG1 and IgG2a levels. These data demonstrate the therapeutic potential of statin-sensitive pathways in allergic airways disease.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Allergens,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Ovalbumin,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0022-1767
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
172
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2903-8
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:14978092-Administration, Oral,
pubmed-meshheading:14978092-Allergens,
pubmed-meshheading:14978092-Animals,
pubmed-meshheading:14978092-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:14978092-Asthma,
pubmed-meshheading:14978092-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:14978092-Cells, Cultured,
pubmed-meshheading:14978092-Cytokines,
pubmed-meshheading:14978092-Disease Models, Animal,
pubmed-meshheading:14978092-Eosinophilia,
pubmed-meshheading:14978092-Epitopes,
pubmed-meshheading:14978092-Female,
pubmed-meshheading:14978092-Injections, Intraperitoneal,
pubmed-meshheading:14978092-Lymph Nodes,
pubmed-meshheading:14978092-Mice,
pubmed-meshheading:14978092-Mice, Inbred BALB C,
pubmed-meshheading:14978092-Ovalbumin,
pubmed-meshheading:14978092-Simvastatin,
pubmed-meshheading:14978092-Th2 Cells
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma.
|
| pubmed:affiliation |
Division of Immunology, Infection, and Inflammation, Section of Respiratory Medicine, University of Glasgow, Glasgow, United Kingdom.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|